Skip to main content

Poster 23: Diabetes pathways for the management of patients at risk

Theodoraki A; Ng KY; Aikins-Andoh C; Hallwainwright S; Sankoh F; Pearse S; Morganstein DL
Diabetes Department, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH
 

Background: Insulin dose adjustment in diabetes is challenging and often patients continue to have poor control despite insulin treatment. Repeated episodes of severe hypoglycaemia increase healthcare costs and can have serious health consequences.    

Poster 22: A series of diabetic ketoacidosis associated with the use of sodium-glucose co-transporter-2 inhibitors in secondary care

Sofia Taverner1, David M Williams2, Cindy Eng1, Rebecca Watson1, Siba George2, Amanda Edwards2, Jeffrey W Stephens2,3

1Department of Acute Medicine, Morriston Hospital, Swansea Bay University Health Board, Swansea, UK;

2Department of Diabetes & Endocrinology, Morriston Hospital, Swansea Bay University Health Board, Swansea, UK;

3Diabetes Research Group, Swansea Unive
 

Poster 16: The characteristics of lean diabetes in a multi-ethnic urban population

Gupta Prakhar; Ladwa Meera
Newham University Hospital, Barts Health NHS Trust
 

Background: Increasing rates of type 2 diabetes in the young have traditionally been associated with overweight and obesity. However, young-onset type 2 diabetes with low-to-normal BMI has been less well studied. We aimed to compare characteristics of lean and non-lean youth with type 2 diabetes.

Poster 15: Revisiting the “Type of Diabetes” in genetically susceptible patients

Chohan, Muhammad Tahir; Abouzaid, Mona; Aggarwal, Naveen
University Hospital North Tees
 

Introduction: Maturity Onset Diabetes of Young (MODY), an autosomal condition accounting for 1-2% of all diabetes usually presents in second to fourth decade. There are various subtypes of MODY with HNF1 alpha (MODY 3) being the most common of all (30-70%).